| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 672304 | Null | 0.0352028253287042 | 0.28520495 |
| NSC 685285 | Null | 0.0352028253287042 | -0.021922376 |
| NSC 700906 | [1-Methyl-4-[1-methyl-4-(3-methoxysulfonyl)propanamido]pyrole-2-carboxamido]propane | 0.0352028253287042 | 0.039252226 |
| NSC 701022 | Null | 0.0352028253287042 | 0.16947669 |
| NSC 703784 | L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride | 0.0352028253287042 | -0.17619366 |
| NSC 719667 | 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one | 0.0352028253287042 | 0.28789315 |
| NSC 726578 | Null | 0.0352028253287042 | -0.015249124 |
| NSC 732962 | 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone | 0.0352028253287042 | 0.048122185 |
| NSC 734949 | 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide | 0.0352028253287042 | 0.32390501 |
| NSC 743532 | Null | 0.0352028253287042 | 0.28418373 |